Decrease of aquaporin-4 and excitatory amino acid transporter-2 indicate astrocyte dysfunction for pathogenesis of cortical degeneration in HIV-associated neurocognitive disorders

Neuropathology

Volumn 37, Issue 1, 2017, Pages 25-34

  Xing, Hui Qin ^a,b   Zhang, Yu ^a,b   Izumo, Kimiko ^a   Arishima, Shiho ^a   Kubota, Ryuji ^a   Ye, Xiang ^b   Xu, Qiping ^b   Mori, Kazuyasu ^c   Izumo, Shuji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b XIAMEN UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

apoptosis of neuron and astrocytes; aquaporin 4; excitatory amino acid transporter 2; HAND; SIVsm543 3

Indexed keywords

AQUAPORIN 4; CASPASE 3; EXCITATORY AMINO ACID TRANSPORTER 2; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN DEGENERATION; BRAIN NERVE CELL; CD4 LYMPHOCYTE COUNT; CELL VACUOLE; CLINICAL FEATURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVATION; FEMALE; FRONTAL CORTEX; HIV ASSOCIATED DEMENTIA; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; ANIMAL; BRAIN; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

AIDS DEMENTIA COMPLEX; ANIMALS; APOPTOSIS; AQUAPORIN 4; ASTROCYTES; BRAIN; CASPASE 3; EXCITATORY AMINO ACID TRANSPORTER 2; FEMALE; MACACA MULATTA; MALE; NEURONS; NEUROPIL; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84982943041     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12321     Document Type: Article

References (30)

1. Antinori A, Arendt G, Becker JT et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69: 1789–1799.
2. Heaton RK, Clifford DB, Franklin DR Jr et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75: 2087–2096.
3. Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J. Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 2008; 20: 25–31.
4. Sacktor N, McDermott MP, Marder K et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002; 8: 136–142.
5. Aylward EH, Henderer JD, McArthur JC et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 1993; 43: 2099–2104.
6. Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991; 337: 1119–1121.
7. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410: 988–994.
8. Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol 1990; 80: 92–94.
9. Masliah E, Heaton RK, Marcotte TD et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997; 42: 963–972.
10. Xing HQ, Moritoyo T, Mori K et al. Simian immunodeficiency virus encephalitis in the white matter and degeneration of the cerebral cortex occur independently in simian immunodeficiency virus-infected monkey. J Neurovirol 2003; 9: 508–518.
11. Xing HQ, Hayakawa H, Izumo K et al. In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases. Neuropathology 2009; 29: 433–442.
12. Xing HQ, Mori K, Sugimoto C et al. Impaired astrocytes and diffuse activation of microglia in the cerebral cortex in simian immunodeficiency virus-infected Macaques without simian immunodeficiency virus encephalitis. J Neuropathol Exp Neurol 2008; 67: 600–611.
13. Aoki-Yoshino K, Uchihara T, Duyckaerts C, Nakamura A, Hauw JJ, Wakayama Y. Enhanced expression of aquaporin 4 in human brain with inflammatory diseases. Acta Neuropathol 2005; 110: 281–288.
14. Papadopoulos MC, Verkman AS. Aquaporin-4 gene disruption in mice reduces brain swelling and mortality in pneumococcal meningitis. J Biol Chem 2005; 280: 13906–13912.
15. Saadoun S, Papadopoulos MC, Watanabe H, Yan D, Manley GT, Verkman AS. Involvement of aquaporin-4 in astroglial cell migration and glial scar formation. J Cell Sci 2005; 118: 5691–5698.
16. Sinclair C, Kirk J, Herron B, Fitzgerald U, McQuaid S. Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol 2007; 113: 187–194.
17. Thiagarajah JR, Papadopoulos MC, Verkman AS. Noninvasive early detection of brain edema in mice by near-infrared light scattering. J Neurosci Res 2005; 80: 293–299.
18. Papadopoulos MC, Krishna S, Verkman AS. Aquaporin water channels and brain edema. The Mount Sinai journal of medicine, New York 2002; 69: 242–248.
19. Manley GT, Fujimura M, Ma T et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000; 6: 159–163.
20. Moftakhar P, Lynch MD, Pomakian JL, Vinters HV. Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2010; 69: 1201–1209.
21. St Hillaire C, Vargas D, Pardo CA et al. Aquaporin 4 is increased in association with human immunodeficiency virus dementia: implications for disease pathogenesis. J Neurovirol 2005; 11: 535–543.
22. Chen Y, Swanson RA. Astrocytes and brain injury. J Cereb Blood Flow Metab 2003; 23: 137–149.
23. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65: 1–105.
24. Zeng XN, Sun XL, Gao L, Fan Y, Ding JH, Hu G. Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol Cell Neurosci 2007; 34: 34–39.
25. Hirsch V, Adger-Johnson D, Campbell B et al. A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol 1997; 71: 1608–1620.
26. Sugimoto C, Watanabe S, Naruse T et al. Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV. PLoS One 2010; 5.e11678
27. Uberla K, Stahl-Hennig C, Bottiger D et al. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc Natl Acad Sci U S A 1995; 92: 8210–8214.
28. Xing HQ, Hayakawa H, Gelpi E, Kubota R, Budka H, Izumo S. Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis. J Neuropathol Exp Neurol 2009; 68: 199–209.
29. Xing HQ, Moritoyo T, Mori K, Sugimoto C, Ono F, Izumo S. Expression of proinflammatory cytokines and its relationship with virus infection in the brain of macaques inoculated with macrophage-tropic simian immunodeficiency virus. Neuropathology 2009; 29: 13–19.
30. Li W, Li G, Steiner J, Nath A. Role of Tat Protein in HIV Neuropathogenesis. Neurotox Res 2009; 16: 205–220.